{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-092020","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.387027+00:00","generated_at":"2026-06-11T09:35:01.541675+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Petros Pharmaceuticals lowers stockholder quorum requirement from majority to one-third","bullets":["Board approved amendment reducing quorum from majority to one-third of outstanding voting shares.","Amendment effective August 15, 2023, applies to all stockholder meetings and class votes.","Change aims to facilitate conducting business at meetings by lowering the attendance threshold."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-092020","json":"https://secwatch.observer/filing/0001104659-23-092020.json","markdown":"https://secwatch.observer/filing/0001104659-23-092020.md","text":"https://secwatch.observer/filing/0001104659-23-092020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/0001104659-23-092020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/tm2323884d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:35:01.541675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d0f36ff3b9c5252940e70a4f3085c193aece0961","claim":"Petros Pharmaceuticals, Inc.: Amended Article III, Section 7 of the bylaws to reduce the stockholder quorum requirement from a majority to one-third of outstanding shares (effective 2023-08-15).","evidence_excerpt":"On August 15, 2023, the board of directors of Petros Pharmaceuticals, Inc. (the “Company”) approved an Amendment (the “Amendment”) to the Company’s Amended and Restated By-laws (the “By-laws”), which became effective as of August 15, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923092020/0001104659-23-092020-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-08-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}